Skip to content

Yoga Based Cardiac Rehabilitation in Heart Failure Failure

Effectiveness of Yoga Based Cardiac Rehabilitation (Yoga-CaRe) in Heart Failure: A Randomized Controlled Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07817589
Acronym
Yoga-CaRe HF
Enrollment
3500
Registered
2026-09-14
Start date
2023-04-24
Completion date
2026-11-30
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure With Reduced Ejection Fraction

Keywords

Heart failure, Yoga, Yoga-CaRe, cardiac rehabilitation, rehabilitation

Brief summary

The clinical study compares the benefits of yoga based rehabilitation programme versus an educational package during recovery of patients with heart failure. Cardiac rehabilitation programmes help patients with cardiac illness to return as quickly as possible to full and productive life and to reduce the chances of further cardiac illness or death. We want to know whether our package of yoga classes can provide effective cardiac rehabilitation and how that compares with a package of educational classes. Both packages are especially designed by us to improve heart health

Interventions

BEHAVIORALYoga-CaRe HF

A cardiac rehabilitation programme comprising of health education and yogic practices.

BEHAVIORALHealth Education

Health education on "Healthy Living with Heart Failure"

Sponsors

Centre for Chronic Disease Control, India
Lead SponsorOTHER
Indian Council of Medical Research
CollaboratorOTHER_GOV
Central Council for Research in Yoga & Naturopathy
CollaboratorUNKNOWN
All India Institute of Medical Sciences
CollaboratorOTHER
All India Institute of Medical Sciences, Bathinda
CollaboratorOTHER_GOV
All India Institute of Medical Sciences, Rishikesh
CollaboratorOTHER_GOV
All India Institute of Medical Sciences, Jodhpur
CollaboratorOTHER_GOV
Dayanand Medical College and Hospital
CollaboratorOTHER
KLES Prabhakar Kore Hospital Belagavi
CollaboratorUNKNOWN
JSS Medical College Hospital
CollaboratorUNKNOWN
SDM College of Medical Sciences & Hospital
CollaboratorOTHER
North Eastern Indira Gandhi Regional Institute of Health ans Medical Sciences
CollaboratorOTHER_GOV
Sri Ramachandra Institute of Higher Education and Research
CollaboratorOTHER
Madras Medical College
CollaboratorOTHER_GOV
Acharya Vinoba Bhave Rural Hospital
CollaboratorUNKNOWN
Sri Jayadeva Institute of Cardiovascular Sciences and Research
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male and female patients above 18years * Physician diagnosed heart failure patients with reduced ejection fraction based on ESC guidelines * Patients should be NYHA class II/III * Willing and able to attend the complete hospital-based CR programme on their own

Exclusion criteria

* Comorbid disease or behavioral or other limitations that interfere with performing Yoga training or prevent the completion of 1 y of exercise training * Elective Cardiovascular procedure or hospitalization planned in the coming 3 months * Currently pregnant or intend to become pregnant in the next year * Heart failure secondary to significant correctable/reversible cause like primary valvular disease/ correctable congential heat disease * Performance of exercise training/yoga at regular intervals (more than once per week) at a moderate-to-vigorous intensity at any time in the previous 6 week * Participation in other clinical trials

Design outcomes

Primary

MeasureTime frameDescription
Major Adverse Cardiovascular eventMedian follow-up of 1 yearTime to first cardiovascular event
Heart Failure Specific Quality of life3 monthsChange in the Minnesota Living with Heart Failure Questionnaire (MLHFQ) total score from baseline. The MLHFQ consists of 21 items, each scored from 0 (no impact) to 5 (very much impacted), with a total score ranging from 0 to 105. Lower scores indicate better health-related quality of life

Secondary

MeasureTime frameDescription
Six minute walk test3 monthsSix-minute walk distance (6MWD), measured as the total distance in metres walked by the participant during a standardized six-minute walk test. A greater distance indicates better functional exercise capacity.
Generic Quality of life3 monthsEuropean Quality of Life (EQ-5D-5L) Questionnaire evaluates five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels. The outcome will be expressed as the EQ-5D-5L utility index score, with higher scores indicating better health-related quality of life.
Self-rated health (EQ-5D-5L)3 monthsEQ-VAS score, ranging from 0 to 100, where 0 represents the worst imaginable health state and 100 represents the best imaginable health state. Higher scores indicate better perceived health status.
Tobacco cessation3 monthsSmoking cessation will be assessed based on self-reported tobacco use status. Current smokers at baseline who report no tobacco use at follow-up will be classified as having achieved tobacco cessation.
Self-reported Frailty3 monthsFrailty assessed by Fried Frailty Phenotype tool
Caregiver's depression - Patient Health Questionnaire-93 monthsPHQ-9 total score, ranging from 0 to 27, with each of the nine items scored from 0 to 3. Higher scores indicate greater severity of depressive symptoms.
Caregiver's Quality of Life - EQ-5D-5Lat 3 monthsQuality of life will be assessed using the EQ-5D-5L questionnaire, which evaluates five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels. The outcome will be expressed as the EQ-5D-5L utility index score and visual analogue scale (EQ-VAS), with higher scores indicating better health-related quality of life.
Costs of careMedian follow-up of 1 yearCost effectiveness as assessed by a piloted tool

Countries

India

Contacts

CONTACTDorairaj Prabhakaran, MD DM
dprabhakaran@ccdcindia.org+91 11 41618456
CONTACTAmbalam M Chandrasekaran, BNYS MPH
Chandrasekaran@ccdcindia.org+91 11 41618456
PRINCIPAL_INVESTIGATORDorairaj Prabhakaran, MD DM (Cardiology)

Centre for Chronic Disease Control, New Delhi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 15, 2026